COVID-19 UPDATE: Moffitt is offering third doses and vaccine booster shots. Learn More
Clinical Trials Search
Clinical Trial 20915
Cancer Type: Breast
Study Type: Treatment
NCT#:
Phase: Phase II
Prinicipal Investigator: Han, Heather
Study Title
A Phase II Study of HER2 directed Dendritic Cell (DC1) vaccine Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients with HER-2 Positive Breast Cancer
Summary
Objective
Therapies
Chemotherapy (NOS); Immunotherapy; Surgery; Vaccine
Medications
DC1 Vaccine (); Herceptin (Trastuzumab); Pertuzumab (); Taxol (paclitaxel); Trastuzumab (); paclitaxel (); rhuMAb HER2 (Trastuzumab)
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
